BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 34112124)

  • 21. HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.
    Huang P; Xu Q; Yan Y; Lu Y; Hu Z; Ou B; Zhang H; Mao K; Zhang J; Wang J; Xiao Z
    Oncogene; 2020 Apr; 39(18):3774-3789. PubMed ID: 32157216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation.
    Sartorius K; An P; Winkler C; Chuturgoon A; Li X; Makarova J; Kramvis A
    Front Immunol; 2021; 12():661204. PubMed ID: 33995383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
    Zhang C; Liu P; Zhang C
    J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
    Yan Y; Huang P; Mao K; He C; Xu Q; Zhang M; Liu H; Zhou Z; Zhou Q; Zhou Q; Ou B; Liu Q; Lin J; Chen R; Wang J; Zhang J; Xiao Z
    Oncogene; 2021 Jan; 40(1):28-45. PubMed ID: 33051595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
    Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
    World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatiotemporal modulation of SMAD4 by HBx is required for cellular proliferation in hepatitis B-related liver cancer.
    Chaomin W; Wenhao N; Jialei H; Ting Z; Honglei F; Zhuang H; Yichao W; Changsen B; Yueguo L
    Cell Oncol (Dordr); 2022 Aug; 45(4):573-589. PubMed ID: 35716259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
    Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
    Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N
    Rao X; Lai L; Li X; Wang L; Li A; Yang Q
    IUBMB Life; 2021 Feb; 73(2):408-417. PubMed ID: 33372396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
    Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
    Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.
    Tian Y; Yang W; Song J; Wu Y; Ni B
    Mol Cell Biol; 2013 Aug; 33(15):2810-6. PubMed ID: 23716588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBV-Induced Increased N6 Methyladenosine Modification of PTEN RNA Affects Innate Immunity and Contributes to HCC.
    Kim GW; Imam H; Khan M; Mir SA; Kim SJ; Yoon SK; Hur W; Siddiqui A
    Hepatology; 2021 Feb; 73(2):533-547. PubMed ID: 32394474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
    Bai PS; Xia N; Sun H; Kong Y
    J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein.
    Hu JL; Liu LP; Yang SL; Fang X; Wen L; Ren QG; Yu C
    Oncol Rep; 2016 Mar; 35(3):1443-8. PubMed ID: 26647960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RPS3a over-expressed in HBV-associated hepatocellular carcinoma enhances the HBx-induced NF-κB signaling via its novel chaperoning function.
    Lim KH; Kim KH; Choi SI; Park ES; Park SH; Ryu K; Park YK; Kwon SY; Yang SI; Lee HC; Sung IK; Seong BL
    PLoS One; 2011; 6(8):e22258. PubMed ID: 21857917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HBx-induced S100A9 in NF-κB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells.
    Duan L; Wu R; Zhang X; Wang D; You Y; Zhang Y; Zhou L; Chen W
    Cell Death Dis; 2018 May; 9(6):629. PubMed ID: 29795379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
    Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
    Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
    World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of Hepatocyte Nuclear Factor 4 α by Long-term Infection of Hepatitis B Virus Contributes to Tumor Cell Proliferation.
    Park S; Ha YN; Dezhbord M; Lee AR; Park ES; Park YK; Won J; Kim NY; Choo SY; Shin JJ; Ahn CH; Kim KH
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
    Yu Z; Feng H; Zhuo Y; Li M; Zhu X; Huang L; Zhang X; Zhou Z; Zheng C; Jiang Y; Le F; Yu DY; Cheng AS; Sun X; Gao Y
    Cell Oncol (Dordr); 2020 Dec; 43(6):1129-1145. PubMed ID: 32623699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.